(换肤)
语言：
西安迈博睿（mabioway）生物科技有限公司是一家研发服务公司，主要从事抗体定制、生物偶联、荧光标记服务，原料产品开发，检测方法建立，尤其是生物大分子药代动力学（PK）、毒代动力学（PK）、免疫原性（ADA）等检测方法。此外还提供重组蛋白表达，分子基因，细胞蛋白，动物模型实验等相关技术服务品。
编程开发 2024-09-14
杭州博沃生物科技有限公司成立于2021年10月，坐落于美丽的钱塘江畔国家高新技术产业开发区，是一家以重组功能蛋白、生物酶制剂为主要方向的研发创新型企业。公司注力打造重组蛋白质高效表达平台、纯化工艺开发平台，自主开发具有独立知识产权的高端生物制品，产品广泛应用于生命科学研究领域、诊断与检测领域和生物医药领域。
网络应用 2023-11-28
WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.
校园学生 2023-11-28
武汉研锦生物科技有限公司专注于:抗体蛋白亲药物和力检测,重组蛋白原料,小分子药物垂钓蛋白靶点,spr亲和力检测等,公司主要有以下平台:计算机辅助药物设计平台、spr药物动力学检测平台、纳米修饰、改造先导化合物平台、以及细胞动物检测药效、毒理等实验平台、致力于靶向药物的前期开发筛选!
编程开发 2023-11-28
烟台科瑞斯生物技术有限责任公司是一家致力于蛋白类产品研发、生产及下游技术开发的企业，产品包括重组蛋白、天然蛋白、流式诊断用试剂等。同时公司提供生物药开发过程的蛋白技术、产品和服务，致力于提供靶向治疗药物研发过程中所需的靶点蛋白及因子类蛋白。
编程开发 2023-11-28